Andrew Witty net worth and biography

Andrew Witty Biography and Net Worth

Sir Andrew Witty was named chief executive officer of UnitedHealth Group in February 2021. As UnitedHealth Group CEO, Sir Andrew is responsible for the strategic direction and overall performance of the enterprise and its long-term growth agenda. He is also a member of the UnitedHealth Group board of directors. Witty was named executive vice president of UnitedHealth Group, and chief executive officer of Optum, in March 2018 and previously served as a UnitedHealth Group company director. From 2008 to 2017, Witty was chief executive officer and a director of the leading pharmaceutical manufacturer GlaxoSmithKline plc (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe. Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Prime Minister’s Research, Innovation and Enterprise Council. Witty became chair, Imperial College Business School Advisory Board, in November 2020. Between April and December 2020 Witty took an unpaid leave as special envoy at the World Health Organization, co-leading the effort to accelerate responses to COVID-19. Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an honorary citizen by Singapore for his contributions to the country’s growth and development. He holds honorary degrees from Exeter, Manchester and Nottingham Universities.

What is Andrew Witty's net worth?

The estimated net worth of Andrew Witty is at least $36.18 million as of July 18th, 2022. Mr. Witty owns 76,559 shares of UnitedHealth Group stock worth more than $36,181,018 as of April 1st. This net worth evaluation does not reflect any other investments that Mr. Witty may own. Learn More about Andrew Witty's net worth.

What is Andrew Witty's salary?

As the CEO of UnitedHealth Group Incorporated, Mr. Witty earned a total compensation package of $18,433,143.00 in 2021. Mr. Witty earned a salary of $1,450,769.00, stock awards of $10,781,573.00, options awards of $3,593,777.00, non-equity compensation of $2,550,000.00, and other compensation of $57,024.00. Learn More on Andrew Witty's salary.

How do I contact Andrew Witty?

The corporate mailing address for Mr. Witty and other UnitedHealth Group executives is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. UnitedHealth Group can also be reached via phone at (952) 936-1300 and via email at [email protected] Learn More on Andrew Witty's contact information.

Has Andrew Witty been buying or selling shares of UnitedHealth Group?

Andrew Witty has not been actively trading shares of UnitedHealth Group during the last ninety days. Most recently, Andrew Witty sold 11,376 shares of the business's stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a transaction totalling $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company's stock, valued at $40,415,496.10. Learn More on Andrew Witty's trading history.

Who are UnitedHealth Group's active insiders?

UnitedHealth Group's insider roster includes Richard Burke (Director), Paul Garcia (Director), Stephen Hemsley (Director), Patricia Lewis (EVP), Dirk McMahon (Pres & COO ), Dirk McMahon (CEO), Frederick McNabb, III (Director), Erin Mcsweeney (EVP), Steven Nelson (CEO), Larry Renfro (Insider), John Rex (CFO), Thomas Roos (CAO), Marianne Short (EVP), Brian Thompson (Exec. VP & CEO of UnitedHealthcare), David Wichmann (CEO), D. Wilson (EVP), and Andrew Witty (CEO). Learn More on UnitedHealth Group's active insiders.

Are insiders buying or selling shares of UnitedHealth Group?

During the last twelve months, UnitedHealth Group insiders bought shares 1 times. They purchased a total of 89 shares worth more than $44,884.48. During the last twelve months, insiders at the healthcare conglomerate sold shares 10 times. They sold a total of 146,390 shares worth more than $78,090,305.48. The most recent insider tranaction occured on December, 7th when EVP Erin Mcsweeney sold 450 shares worth more than $244,035.00. Insiders at UnitedHealth Group own 0.4% of the company. Learn More about insider trades at UnitedHealth Group.

Information on this page was last updated on 12/7/2022.

Andrew Witty Insider Trading History at UnitedHealth Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Sell11,376$527.90$6,005,390.4076,559View SEC Filing Icon  
7/21/2021Sell6,000$414.15$2,484,900.00View SEC Filing Icon  
See Full Table

Andrew Witty Buying and Selling Activity at UnitedHealth Group

This chart shows Andrew Witty's buying and selling at UnitedHealth Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UnitedHealth Group Company Overview

UnitedHealth Group logo
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.
Read More

Today's Range

Now: $472.59
Low: $470.10
High: $476.00

50 Day Range

MA: $480.57
Low: $460.33
High: $499.19

2 Week Range

Now: $472.59
Low: $449.70
High: $558.10


3,996,695 shs

Average Volume

3,119,892 shs

Market Capitalization

$440.86 billion

P/E Ratio


Dividend Yield